Omalizumab reduces exacerbation rate in children with asthma – Healio

Omalizumab reduces exacerbation rate in children with asthma
Healio
Teach and colleagues conducted a double blind, double placebo-controlled study of 478 children with asthma aged 6 to 17 years old who lived in the inner city. Study participants — all of whom had a recent asthma exacerbation — were randomly assigned

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.